178 related articles for article (PubMed ID: 26708993)
1. Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.
Kibel AS; Ahn J; Isikbay M; Klim A; Wu WS; Hayes RB; Isaacs WB; Daw EW
Prostate; 2016 Apr; 76(5):479-90. PubMed ID: 26708993
[TBL] [Abstract][Full Text] [Related]
2. Association between polymorphisms in cell cycle genes and advanced prostate carcinoma.
Kibel AS; Jin CH; Klim A; Luly J; A Roehl K; Wu WS; Suarez BK
Prostate; 2008 Aug; 68(11):1179-86. PubMed ID: 18459109
[TBL] [Abstract][Full Text] [Related]
3. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
Duggan D; Zheng SL; Knowlton M; Benitez D; Dimitrov L; Wiklund F; Robbins C; Isaacs SD; Cheng Y; Li G; Sun J; Chang BL; Marovich L; Wiley KE; Bälter K; Stattin P; Adami HO; Gielzak M; Yan G; Sauvageot J; Liu W; Kim JW; Bleecker ER; Meyers DA; Trock BJ; Partin AW; Walsh PC; Isaacs WB; Grönberg H; Xu J; Carpten JD
J Natl Cancer Inst; 2007 Dec; 99(24):1836-44. PubMed ID: 18073375
[TBL] [Abstract][Full Text] [Related]
4. Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.
Lavender NA; Rogers EN; Yeyeodu S; Rudd J; Hu T; Zhang J; Brock GN; Kimbro KS; Moore JH; Hein DW; Kidd LC
BMC Med Genomics; 2012 Apr; 5():11. PubMed ID: 22546513
[TBL] [Abstract][Full Text] [Related]
5. Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.
Xie CC; Lu L; Sun J; Zheng SL; Isaacs WB; Gronberg H; Xu J
J Hum Genet; 2011 Jul; 56(7):496-502. PubMed ID: 21633361
[TBL] [Abstract][Full Text] [Related]
6. Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African Americans.
Koboldt DC; Kanchi KL; Gui B; Larson DE; Fulton RS; Isaacs WB; Kraja A; Borecki IB; Jia L; Wilson RK; Mardis ER; Kibel AS
Cancer Epidemiol Biomarkers Prev; 2016 Nov; 25(11):1456-1463. PubMed ID: 27486019
[TBL] [Abstract][Full Text] [Related]
7. Association of CD14 variant with prostate cancer in African American men.
Mason TE; Ricks-Santi L; Chen W; Apprey V; Joykutty J; Ahaghotu C; Kittles R; Bonney G; Dunston GM
Prostate; 2010 Feb; 70(3):262-9. PubMed ID: 19830784
[TBL] [Abstract][Full Text] [Related]
8. Genetic ancestry and prostate cancer susceptibility SNPs in Puerto Rican and African American men.
Irizarry-Ramírez M; Kittles RA; Wang X; Salgado-Montilla J; Nogueras-González GM; Sánchez-Ortiz R; Guerrios L; Rivera K; Shah E; Prokhorova I; Roberson P; Troncoso P; Pettaway CA
Prostate; 2017 Jul; 77(10):1118-1127. PubMed ID: 28543179
[TBL] [Abstract][Full Text] [Related]
9. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.
Sun J; Purcell L; Gao Z; Isaacs SD; Wiley KE; Hsu FC; Liu W; Duggan D; Carpten JD; Grönberg H; Xu J; Chang BL; Partin AW; Walsh PC; Isaacs WB; Zheng SL
Prostate; 2008 May; 68(7):691-7. PubMed ID: 18361410
[TBL] [Abstract][Full Text] [Related]
10. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.
Chen F; Madduri RK; Rodriguez AA; Darst BF; Chou A; Sheng X; Wang A; Shen J; Saunders EJ; Rhie SK; Bensen JT; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Stanford JL; Zheng W; Sanderson M; John EM; Park JY; Xu J; Wang Y; Berndt SI; Huff CD; Yeboah ED; Tettey Y; Lachance J; Tang W; Rentsch CT; Cho K; Mcmahon BH; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Sellers TA; Yamoah K; Murphy AB; Crawford DC; Patel AV; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas CM; Stern MC; Kote-Jarai Z; Govindasami K; Cook MB; Chokkalingam AP; Hsing AW; Goodman PJ; Hoffmann TJ; Drake BF; Hu JJ; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Idowu MO; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Diop H; Van Den Eeden SK; Blanchet P; Fowke JH; Casey G; Hennis AJ; Lubwama A; Thompson IM; Leach R; Easton DF; Preuss MH; Loos RJ; Gundell SM; Wan P; Mohler JL; Fontham ET; Smith GJ; Taylor JA; Srivastava S; Eeles RA; Carpten JD; Kibel AS; Multigner L; Parent MÉ; Menegaux F; Cancel-Tassin G; Klein EA; Andrews C; Rebbeck TR; Brureau L; Ambs S; Edwards TL; Watya S; Chanock SJ; Witte JS; Blot WJ; Michael Gaziano J; Justice AC; Conti DV; Haiman CA
Eur Urol; 2023 Jul; 84(1):13-21. PubMed ID: 36872133
[TBL] [Abstract][Full Text] [Related]
11. Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma.
Lubahn J; Berndt SI; Jin CH; Klim A; Luly J; Wu WS; Isaacs S; Wiley K; Isaacs WB; Suarez BK; Hayes RB; Kibel AS
Prostate; 2010 May; 70(6):646-53. PubMed ID: 20033885
[TBL] [Abstract][Full Text] [Related]
12. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
Robbins CM; Hernandez W; Ahaghotu C; Bennett J; Hoke G; Mason T; Pettaway CA; Vijayakumar S; Weinrich S; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD; Kittles RA
Prostate; 2008 Dec; 68(16):1790-7. PubMed ID: 18767027
[TBL] [Abstract][Full Text] [Related]
13. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
[TBL] [Abstract][Full Text] [Related]
14. NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans.
Hooker S; Bonilla C; Akereyeni F; Ahaghotu C; Kittles RA
Prostate Cancer Prostatic Dis; 2008; 11(4):349-56. PubMed ID: 18026184
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer susceptibility Loci identified on chromosome 12 in African Americans.
Bonilla C; Hooker S; Mason T; Bock CH; Kittles RA
PLoS One; 2011 Feb; 6(2):e16044. PubMed ID: 21358824
[TBL] [Abstract][Full Text] [Related]
16. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.
Kibel AS; Suarez BK; Belani J; Oh J; Webster R; Brophy-Ebbers M; Guo C; Catalona WJ; Picus J; Goodfellow PJ
Cancer Res; 2003 May; 63(9):2033-6. PubMed ID: 12727815
[TBL] [Abstract][Full Text] [Related]
17. Association of testis derived transcript gene variants and prostate cancer risk.
Liu X; Cicek MS; Plummer SJ; Jorgenson E; Casey G; Witte JS
J Urol; 2007 Mar; 177(3):894-8. PubMed ID: 17296370
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor genetic polymorphisms are associated with PSA level, Gleason score and prostate cancer risk in African-American men.
Jingwi EY; Abbas M; Ricks-Santi L; Winchester D; Beyene D; Day A; Naab TJ; Kassim OO; Dunston GM; Copeland RL; Kanaan YM
Anticancer Res; 2015 Mar; 35(3):1549-58. PubMed ID: 25750310
[TBL] [Abstract][Full Text] [Related]
19. Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
Xu J; Zheng SL; Isaacs SD; Wiley KE; Wiklund F; Sun J; Kader AK; Li G; Purcell LD; Kim ST; Hsu FC; Stattin P; Hugosson J; Adolfsson J; Walsh PC; Trent JM; Duggan D; Carpten J; Grönberg H; Isaacs WB
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2136-40. PubMed ID: 20080650
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations in PPFIBP2 are associated with lethal prostate cancer.
Wu Y; Yu H; Zheng SL; Feng B; Kapron AL; Na R; Boyle JL; Shah S; Shi Z; Ewing CM; Wiley KE; Luo J; Walsh PC; Carter HB; Helfand BT; Cooney KA; Xu J; Isaacs WB
Prostate; 2018 Dec; 78(16):1222-1228. PubMed ID: 30043417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
